Dongbao Bio-Tech released its performance for the first half of the year, with a net profit attributable to the parent company of 36.9673 million yuan, a decrease of 28.00%
I'm PortAI, I can summarize articles.
Dongbao Bio-Tech released its semi-annual report for 2025, with operating revenue of 369 million yuan, a year-on-year decrease of 16.93%; net profit attributable to the parent company was 36.9673 million yuan, a year-on-year decline of 28.00%; net profit excluding non-recurring gains and losses was 33.4351 million yuan, a year-on-year decrease of 27.41%; basic earnings per share were 0.0629 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments